EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹852 Cr |
| Mar2024 | ₹1,097 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹768 Cr |
| Mar2021 | ₹704 Cr |
How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹852 Cr | -22.38 | |
| Mar2024 | ₹1,097 Cr | 46.92 | |
| Mar2023 | ₹747 Cr | -2.78 | |
| Mar2022 | ₹768 Cr | 9.05 | |
| Mar2021 | ₹704 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,849.8 Cr | -0.6% | 8.2% | 40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.6% |
8.2% |
40.6% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses